A Michael Lincoff Selected Research

Heparin (Liquaemin)

1/2018	Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis.
2/2016	Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.
1/2016	Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials).
4/2013	Pharmacotherapy During Saphenous Vein Graft Intervention.
6/2011	Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux.
6/2011	Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
2/2011	Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.
1/2011	Bleeding complications of unfractionated heparin.
3/2010	The use and limitations of unfractionated heparin.
1/2010	Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Michael Lincoff Research Topics

Disease

65	Hemorrhage 01/2020 - 05/2002
61	Myocardial Infarction 01/2021 - 05/2002
49	Acute Coronary Syndrome 01/2020 - 08/2003
22	Thrombosis (Thrombus) 01/2021 - 05/2002
20	ST Elevation Myocardial Infarction 01/2022 - 07/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2002
20	Stroke (Strokes) 01/2021 - 03/2006
18	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 08/2003
16	Type 2 Diabetes Mellitus (MODY) 05/2021 - 09/2007
16	Ischemia 01/2019 - 07/2002
12	Unstable Angina 10/2020 - 06/2003
9	Inflammation (Inflammations) 11/2020 - 03/2002
9	Vascular Diseases (Vascular Disease) 10/2020 - 09/2007
9	Diabetes Mellitus 01/2020 - 06/2004
7	Infarction (Infarctions) 11/2020 - 07/2002
7	Heart Failure 11/2020 - 08/2003
7	Anemia 12/2014 - 07/2004
6	Coronary Disease (Coronary Heart Disease) 01/2018 - 05/2002
6	Hyperplasia 04/2006 - 04/2002
5	Rheumatoid Arthritis 01/2018 - 04/2009
5	Osteoarthritis 01/2018 - 04/2009
5	Atherosclerosis 01/2014 - 08/2005
5	Vascular System Injuries 08/2005 - 10/2002
4	Chronic Renal Insufficiency 01/2018 - 05/2002
4	Thrombocytopenia (Thrombopenia) 06/2008 - 11/2004
3	Peripheral Arterial Disease 01/2021 - 10/2006
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2002
3	Arthritis (Polyarthritis) 11/2017 - 04/2009
3	Hypersensitivity (Allergy) 12/2016 - 06/2008
3	Non-ST Elevated Myocardial Infarction 02/2015 - 08/2003
3	Renal Insufficiency (Renal Failure) 02/2009 - 04/2002
2	Disease Progression 01/2021 - 04/2008
2	Death (Near-Death Experience) 01/2021 - 01/2021
2	Hypertriglyceridemia 12/2020 - 10/2018
2	Heart Diseases (Heart Disease) 11/2020 - 03/2008
2	Hyperglycemia 11/2020 - 01/2010
2	Hypertension (High Blood Pressure) 11/2017 - 04/2002

Drug/Important Bio-Agent (IBA)

45	bivalirudin (Angiomax)FDA Link 01/2018 - 05/2002
43	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 05/2002
28	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2002
15	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 02/2003
13	Clopidogrel (Plavix)FDA Link 11/2014 - 07/2006
12	Abciximab (ReoPro)FDA Link 10/2007 - 04/2002
11	aleglitazarIBA 01/2020 - 07/2009
9	Pharmaceutical PreparationsIBA 01/2021 - 06/2002
9	evacetrapibIBA 10/2020 - 12/2015
9	AnticoagulantsIBA 01/2020 - 05/2002
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 07/2006
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 07/2009
7	Insulin (Novolin)FDA Link 01/2021 - 04/2008
7	LipidsIBA 01/2021 - 11/2003
7	omega-Chloroacetophenone (Mace)IBA 01/2021 - 02/2011
7	Cholesterol Ester Transfer ProteinsIBA 01/2020 - 12/2015
7	AntithrombinsIBA 05/2008 - 05/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 10/2018
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2003
6	Celecoxib (Celebrex)FDA Link 01/2018 - 01/2005
6	Enoxaparin (Lovenox)FDA LinkGeneric 09/2008 - 01/2003
5	Naproxen (Naprosyn)FDA LinkGeneric 01/2018 - 04/2009
5	Ibuprofen (Motrin)FDA LinkGeneric 01/2018 - 04/2009
5	Platelet Membrane GlycoproteinsIBA 02/2008 - 11/2002
4	CholesterolIBA 01/2021 - 08/2014
4	C-Reactive ProteinIBA 10/2020 - 02/2011
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2007
4	Pioglitazone (Actos)FDA Link 11/2014 - 09/2007
4	MB Form Creatine KinaseIBA 10/2014 - 03/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2008 - 11/2006
4	Eptifibatide (Integrilin)FDA Link 02/2008 - 01/2003
4	reteplase FDA Link 10/2007 - 07/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2016
3	CSL112IBA 01/2021 - 10/2016
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 04/2009
3	AntibodiesIBA 12/2016 - 02/2007
3	CreatinineIBA 06/2011 - 10/2003
3	cangrelorIBA 12/2009 - 02/2003
3	P-SelectinIBA 08/2005 - 07/2002
3	LigandsIBA 05/2003 - 07/2002
2	Corn Oil (Oil, Corn)IBA 05/2021 - 12/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2019
2	HDL CholesterolIBA 12/2020 - 01/2019
2	Lipoprotein(a)IBA 10/2020 - 01/2020
2	varespladibIBA 01/2019 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
2	Triglycerides (Triacylglycerol)IBA 10/2018 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2013
2	RB 006IBA 12/2016 - 01/2016
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016 - 07/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014 - 11/2008
2	Adenosine Diphosphate (ADP)IBA 11/2012 - 02/2003

Therapy/Procedure

60	Therapeutics 01/2021 - 01/2002
51	Percutaneous Coronary Intervention 01/2022 - 05/2002
23	Stents 01/2021 - 04/2002
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 12/2002
8	Drug-Eluting Stents 01/2021 - 07/2006
8	Thrombolytic Therapy 10/2014 - 11/2002
6	Blood Transfusion (Blood Transfusions) 06/2011 - 01/2003
4	Drug Therapy (Chemotherapy) 01/2021 - 02/2009
4	Secondary Prevention 10/2020 - 11/2003
4	Glycemic Control 01/2020 - 09/2007
2	Patient Readmission 10/2017 - 01/2012